Former FDA Commissioner Dr. Scott Gottlieb visited the Eagle Facility on Thursday, October 10th, 2019. Eagle President and CEO Dr. Ross Caputo took the opportunity to share our mission…
Dr. Scott Gottlieb Tours the New Eagle Facility
Former FDA Commissioner Dr. Scott Gottlieb visited the Eagle Facility on Thursday, October 10th, 2019. Eagle President and CEO Dr. Ross Caputo took the opportunity to share our mission…
EagleTrax Sample Management System
EagleTrax is our new full-featured system that allows you to track your samples, print reports at the click of…
EagleTrax Sample Management System
EagleTrax is our new full-featured system that allows you to track your samples, print reports at the click of…
Testing Alone is not Enough
A common misconception is the belief that finished product testing is sufficient to demonstrate quality. However, facilities that perform…
Testing Alone is not Enough
A common misconception is the belief that finished product testing is sufficient to demonstrate quality. However, facilities that perform…
Take a Tour of Our New Facility
Eagle’s state-of-the-art 35,000 square foot facility and laboratory feature innovative technologies and more lab space so we can increase…
Take a Tour of Our New Facility
Eagle’s state-of-the-art 35,000 square foot facility and laboratory feature innovative technologies and more lab space so we can increase…
EagleTrax Tutorial Video
EagleTrax is our new full-featured system which allows you to track your samples, print reports at the click of…
EagleTrax Tutorial Video
EagleTrax is our new full-featured system which allows you to track your samples, print reports at the click of…
Tracking Your Sample’s Progress Just Became Possible.
We’re pleased to announce EagleTrax™ EagleTrax is our new customer portal that allows you to track your sample as…
Tracking Your Sample’s Progress Just Became Possible.
We’re pleased to announce EagleTrax™ EagleTrax is our new customer portal that allows you to track your sample as…
A Summary of Proposed Changes to USP 797
Some of the changes are significant and will require major adjustments in pharmacy systems and processes, while other changes will be easier to accommodate.
A Summary of Proposed Changes to USP 797
Some of the changes are significant and will require major adjustments in pharmacy systems and processes, while other changes will be easier to accommodate.
Insanitary Conditions in Compounding Pharmacies: The Regulatory Framework
In the wake of the 2012 tragedy caused by contaminated drugs produced at the New England Compounding Center, Congress…
Insanitary Conditions in Compounding Pharmacies: The Regulatory Framework
In the wake of the 2012 tragedy caused by contaminated drugs produced at the New England Compounding Center, Congress…
Important Considerations For Cleanroom Design
When designing a cleanroom, there are many aspects to take into consideration. While regulations and guidelines such as USP…
Important Considerations For Cleanroom Design
When designing a cleanroom, there are many aspects to take into consideration. While regulations and guidelines such as USP…
FDA Inspections of Compounding Pharmacies
The U.S. Food and Drug Administration (FDA) inspects both 503A and 503B compounding pharmacies to assess if procedures, practices,…
FDA Inspections of Compounding Pharmacies
The U.S. Food and Drug Administration (FDA) inspects both 503A and 503B compounding pharmacies to assess if procedures, practices,…
